Company subsidiary hVIVO will conduct study with a US biotech
Category: Uncategorized
PARP inhibitor approved for new ovarian and prostate cancer indications
Around 400,000 people in the UK are living with rheumatoid arthritis
Label extension includes eligible infants aged four months or older
An enzyme that helps COVID-19 (coronavirus) infect the body also plays a role in inflammation and patient outcomes […]
Updated Date: Thu, 29 Oct 2020 00:00:00 EDT
Updated Date: Thu, 29 Oct 2020 00:00:00 EDT
Updated Date: Thu, 29 Oct 2020 00:00:00 EDT
Updated Date: Thu, 29 Oct 2020 00:00:00 EDT
Updated Date: Thu, 29 Oct 2020 00:00:00 EDT